Platelet Additive Solutions (PAS) - SEABB
Platelet Additive Solutions (PAS) Jose Lima, MD Medical Director, Southern Region March 2012
Download Platelet Additive Solutions (PAS) - SEABB
Information
Domain:
Source:
Link to this page:
Documents from same domain
TACO vs. TRALI - SEABB
www.seabb.orgTACO vs. TRALI: Recognition, Differentiation, and Investigation of Pulmonary Transfusion Reactions Shealynn Harris, M.D. Assistant Medical Director
Good Manufacturing Practices (GMPs) - SEABB
www.seabb.orgWhere Do We Find Them? • Depends on what you want…. • Are you looking for good manufacturing practices for – Blood and Blood Products – Tissues (HCT/Ps)
Blood Bank--- Reviewing the basics
www.seabb.orgGive blood. TM Sample Age: AABB Std 5.13.3.2 “If the patient has been transfused in the preceding 3 months with blood or a component containing allogeneic red cells, has been pregnant within the preceding 3 months, or the history is uncertain or unavailable, a sample shall be obtained from the patient within 3 days of the scheduled transfusion.
Related documents
FLOSEAL Hemostatic Matrix, 5 mL
floseal.comFLOSEAL Hemostatic Matrix, 5 mL Instructions for Use Caution: Federal Law (United States) restricts this device to sale by or on the order of a licensed healthcare practitioner.
AEROSPACE MEDICAL SERVICE SPECIALTY …
static.e-publishing.af.milqtp 4n0x1-2 . july 2014 . aerospace medical service specialty . nursing care of patients with special needs . total force, total care – everytime, anywhere
Product Information Plasma-Lyte 148 Replacement …
www.baxterhealthcare.com.auPlasma-Lyte 148 Replacement PI 05Jul2013 Page 3 of 8 ccsi41920130326 Baxter In patients with diminished renal function, administration of Plasma-Lyte 148 Replacement IV Infusion may
PRODUCT INFORMATION SODIUM CHLORIDE …
www.baxterhealthcare.com.auPI_0.9% Sodium Chloride (AVIVA)_22Oct 2013 4 When selecting the type of infusion solution and the volume/rate of infusion for a elderly patient,
Data Sheet 3% Citanest DENTAL with Octapressin
www.medsafe.govt.nzData Sheet. 3% Citanest ® DENTAL. with Octapressin ® Prilocaine 30 mg/mL, felypressin 0.54 µg/mL. Presentation. 3% Citanest® DENTAL with Octapressin® solution for injection is a sterile isotonic aqueous
Patient Safety Solutions | volume 1, solution 1 | …
www.who.intWHO Collaborating Centre for Patient Safety Solutions Aide Memoire Statement of Problem and ImPact: The existence of confusing drug names is one of the most com-
Patient Safety Solutions | volume 1, solution 3 | …
www.who.intWHO Collaborating Centre for Patient Safety Solutions Aide Memoire Statement of Problem and ImPact: During an episode of disease or period of care, a patient can
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.ukPage 1 of 6 Package leaflet: Information for the user Zinforo ® 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil
Related search queries
FLOSEAL Hemostatic Matrix, 5 mL, AEROSPACE MEDICAL SERVICE SPECIALTY, Aerospace medical service specialty . nursing, Product Information Plasma-Lyte 148 Replacement, PRODUCT INFORMATION SODIUM CHLORIDE, Solution, Volume, Patient, Prilocaine, Patient Safety Solutions, Volume 1, Solution 1, Patient Safety Solutions | volume 1, solution 3 |, Package leaflet: Information for the user